Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Genetic susceptibility to hepatic sinusoidal obstruction syndrome in pediatric patients undergoing HSCT.

Ansari M, Petrykey K, Rezgui MA, Vecchio VD, Cortyl J, Ralph RO, Nava T, Beaulieu P, St-Onge P, Mlakar SJ, Curtis PH, Uppugunduri CRS, Lesne L, Théoret Y, Chalandon Y, Bartelink IH, Boelens JJ, Bredius RGM, Dalle JH, Lewis V, Kangarloo BS, Peters C, Sinnett D, Bittencourt H, Krajinovic M.

Biol Blood Marrow Transplant. 2019 Nov 29. pii: S1083-8791(19)30832-8. doi: 10.1016/j.bbmt.2019.11.026. [Epub ahead of print]

PMID:
31790828
2.

Functional flow cytometry of monocytes for routine diagnosis of innate primary immunodeficiencies.

Ammann S, Fuchs S, Martin-Martin L, Castro CN, Spielberger B, Klemann C, Elling R, Heeg M, Speckmann C, Hainmann I, Kaiser-Labusch P, Horneff G, Thalhammer J, Bredius RG, Stadt UZ, Lehmberg K, Fuchs I, von Spee-Mayer C, Henneke P, Ehl S.

J Allergy Clin Immunol. 2019 Sep 14. pii: S0091-6749(19)31186-8. doi: 10.1016/j.jaci.2019.09.002. [Epub ahead of print] No abstract available.

PMID:
31526803
3.

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.

Admiraal R, Jol-van der Zijde CM, Furtado Silva JM, Knibbe CAJ, Lankester AC, Boelens JJ, Hale G, Etuk A, Wilson M, Adams S, Veys P, van Kesteren C, Bredius RGM.

Clin Pharmacokinet. 2019 Dec;58(12):1609-1620. doi: 10.1007/s40262-019-00782-0.

PMID:
31131436
4.

Effects of immunomodulation in classic infantile Pompe patients with high antibody titers.

Poelman E, Hoogeveen-Westerveld M, van den Hout JMP, Bredius RGM, Lankester AC, Driessen GJA, Kamphuis SSM, Pijnappel WWM, van der Ploeg AT.

Orphanet J Rare Dis. 2019 Mar 22;14(1):71. doi: 10.1186/s13023-019-1039-z.

5.

Differential Elimination of Anti-Thymocyte Globulin of Fresenius and Genzyme Impacts T-Cell Reconstitution After Hematopoietic Stem Cell Transplantation.

Oostenbrink LVE, Jol-van der Zijde CM, Kielsen K, Jansen-Hoogendijk AM, Ifversen M, Müller KG, Lankester AC, van Halteren AGS, Bredius RGM, Schilham MW, van Tol MJD.

Front Immunol. 2019 Mar 6;10:315. doi: 10.3389/fimmu.2019.00315. eCollection 2019.

6.

Cost-effectiveness of newborn screening for severe combined immunodeficiency.

Van der Ploeg CPB, Blom M, Bredius RGM, van der Burg M, Schielen PCJI, Verkerk PH, Van den Akker-van Marle ME.

Eur J Pediatr. 2019 May;178(5):721-729. doi: 10.1007/s00431-019-03346-3. Epub 2019 Feb 25.

PMID:
30805731
7.

Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation.

Bekker V, Zwittink RD, Knetsch CW, Sanders IMJG, Berghuis D, Heidt PJ, Vossen JMJJ, de Vos WM, Belzer C, Bredius RGM, Van't Hof PJ, Lankester AC, Kuijper EJ.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1164-1171. doi: 10.1016/j.bbmt.2019.01.037. Epub 2019 Feb 5.

PMID:
30731251
8.

Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study.

Ferrua F, Galimberti S, Courteille V, Slatter MA, Booth C, Moshous D, Neven B, Blanche S, Cavazzana M, Laberko A, Shcherbina A, Balashov D, Soncini E, Porta F, Al-Mousa H, Al-Saud B, Al-Dhekri H, Arnaout R, Formankova R, Bertrand Y, Lange A, Smart J, Wolska-Kusnierz B, Aquino VM, Dvorak CC, Fasth A, Fouyssac F, Heilmann C, Hoenig M, Schuetz C, Kelečić J, Bredius RGM, Lankester AC, Lindemans CA, Suarez F, Sullivan KE, Albert MH, Kałwak K, Barlogis V, Bhatia M, Bordon V, Czogala W, Alonso L, Dogu F, Gozdzik J, Ikinciogullari A, Kriván G, Ljungman P, Meyts I, Mustillo P, Smith AR, Speckmann C, Sundin M, Keogh SJ, Shaw PJ, Boelens JJ, Schulz AS, Sedlacek P, Veys P, Mahlaoui N, Janda A, Davies EG, Fischer A, Cowan MJ, Gennery AR; SCETIDE, PIDTC, EBMT & ESID IEWP.

J Allergy Clin Immunol. 2019 Jun;143(6):2238-2253. doi: 10.1016/j.jaci.2018.12.1010. Epub 2019 Jan 17.

9.

Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.

Aydin SE, Freeman AF, Al-Herz W, Al-Mousa HA, Arnaout RK, Aydin RC, Barlogis V, Belohradsky BH, Bonfim C, Bredius RG, Chu JI, Ciocarlie OC, Doğu F, Gaspar HB, Geha RS, Gennery AR, Hauck F, Hawwari A, Hickstein DD, Hoenig M, Ikinciogullari A, Klein C, Kumar A, Ifversen MRS, Matthes S, Metin A, Neven B, Pai SY, Parikh SH, Picard C, Renner ED, Sanal Ö, Schulz AS, Schuster F, Shah NN, Shereck EB, Slatter MA, Su HC, van Montfrans J, Woessmann W, Ziegler JB, Albert MH; Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the European Society for Primary Immunodeficiencies.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):848-855. doi: 10.1016/j.jaip.2018.10.035. Epub 2018 Nov 2.

PMID:
30391550
10.

Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.

Jacobse J, Mensink H, van der Stoep-Yap MYEC, Kollen WJW, Bresters D, Bredius RGM.

Bone Marrow Transplant. 2018 Oct;53(10):1372-1374. doi: 10.1038/s41409-018-0231-4. Epub 2018 May 24. No abstract available.

PMID:
29795419
11.

Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.

Kruizinga MD, van Tol MJD, Bekker V, Netelenbos T, Smiers FJ, Bresters D, Jansen-Hoogendijk AM, van Ostaijen-Ten Dam MM, Kollen WJW, Zwaginga JJ, Lankester AC, Bredius RGM.

Biol Blood Marrow Transplant. 2018 Apr;24(4):772-778. doi: 10.1016/j.bbmt.2017.12.782. Epub 2017 Dec 19.

12.

Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Barzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, Nademi Z, Slatter MA, Ulloa ER, Shcherbina A, Roppelt A, Worth A, Silva J, Aiuti A, Murguia-Favela L, Speckmann C, Carneiro-Sampaio M, Fernandes JF, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Schulz A, Steinmann S, Notarangelo LD, Gambineri E, Lionetti P, Shearer WT, Forbes LR, Martinez C, Moshous D, Blanche S, Fisher A, Ruemmele FM, Tissandier C, Ouachee-Chardin M, Rieux-Laucat F, Cavazzana M, Qasim W, Lucarelli B, Albert MH, Kobayashi I, Alonso L, Diaz De Heredia C, Kanegane H, Lawitschka A, Seo JJ, Gonzalez-Vicent M, Diaz MA, Goyal RK, Sauer MG, Yesilipek A, Kim M, Yilmaz-Demirdag Y, Bhatia M, Khlevner J, Richmond Padilla EJ, Martino S, Montin D, Neth O, Molinos-Quintana A, Valverde-Fernandez J, Broides A, Pinsk V, Ballauf A, Haerynck F, Bordon V, Dhooge C, Garcia-Lloret ML, Bredius RG, Kałwak K, Haddad E, Seidel MG, Duckers G, Pai SY, Dvorak CC, Ehl S, Locatelli F, Goldman F, Gennery AR, Cowan MJ, Roncarolo MG, Bacchetta R; Primary Immune Deficiency Treatment Consortium (PIDTC) and the Inborn Errors Working Party (IEWP) of the European Society for Blood and Marrow Transplantation (EBMT).

J Allergy Clin Immunol. 2018 Mar;141(3):1036-1049.e5. doi: 10.1016/j.jaci.2017.10.041. Epub 2017 Dec 11.

13.

High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.

van der Stoep MYEC, Bertaina A, Ten Brink MH, Bredius RG, Smiers FJ, Wanders DCM, Moes DJAR, Locatelli F, Guchelaar HJ, Zwaveling J, Lankester AC.

Br J Haematol. 2017 Dec;179(5):772-780. doi: 10.1111/bjh.14960. Epub 2017 Oct 19.

PMID:
29048102
14.

An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program.

Blom M, Pico-Knijnenburg I, Sijne-van Veen M, Boelen A, Bredius RGM, van der Burg M, Schielen PCJI.

Clin Immunol. 2017 Jul;180:106-110. doi: 10.1016/j.clim.2017.05.007. Epub 2017 May 6.

PMID:
28487086
15.

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients.

Bank JR, Heidt S, Moes DJ, Roelen DL, Mallat MJ, van der Boog PJ, Vergunst M, Jol-van der Zijde CM, Bredius RG, Braat AE, Ringers J, van Tol MJ, Claas FH, Reinders ME, de Fijter JW.

Transplant Direct. 2016 Dec 19;3(1):e124. doi: 10.1097/TXD.0000000000000634. eCollection 2017 Jan.

16.

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.

Admiraal R, Nierkens S, de Witte MA, Petersen EJ, Fleurke GJ, Verrest L, Belitser SV, Bredius RGM, Raymakers RAP, Knibbe CAJ, Minnema MC, van Kesteren C, Kuball J, Boelens JJ.

Lancet Haematol. 2017 Apr;4(4):e183-e191. doi: 10.1016/S2352-3026(17)30029-7. Epub 2017 Mar 16. Erratum in: Lancet Haematol. 2017 May;4(5):e201.

PMID:
28330607
17.

The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.

Kruizinga MD, Bresters D, Smiers FJ, Lankester AC, Bredius RGM.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26453. Epub 2017 Jan 11.

PMID:
28074607
18.

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, Bredius RG, Egberts AC, Bierings M, Kletzel M, Shaw PJ, Nath CE, Hempel G, Ansari M, Krajinovic M, Théorêt Y, Duval M, Keizer RJ, Bittencourt H, Hassan M, Güngör T, Wynn RF, Veys P, Cuvelier GD, Marktel S, Chiesa R, Cowan MJ, Slatter MA, Stricherz MK, Jennissen C, Long-Boyle JR, Boelens JJ.

Lancet Haematol. 2016 Nov;3(11):e526-e536. doi: 10.1016/S2352-3026(16)30114-4. Epub 2016 Oct 13.

19.

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Cicalese MP, Ferrua F, Castagnaro L, Pajno R, Barzaghi F, Giannelli S, Dionisio F, Brigida I, Bonopane M, Casiraghi M, Tabucchi A, Carlucci F, Grunebaum E, Adeli M, Bredius RG, Puck JM, Stepensky P, Tezcan I, Rolfe K, De Boever E, Reinhardt RR, Appleby J, Ciceri F, Roncarolo MG, Aiuti A.

Blood. 2016 Jul 7;128(1):45-54. doi: 10.1182/blood-2016-01-688226. Epub 2016 Apr 29. Erratum in: Blood. 2017 Jun 15;129(24):3271.

20.

Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients.

de Vor IC, van der Meulen PM, Bekker V, Verhard EM, Breuning MH, Harnisch E, van Tol MJ, Wieringa JW, van de Vosse E, Bredius RG.

J Clin Immunol. 2016 Apr;36(3):195-203. doi: 10.1007/s10875-016-0244-y. Epub 2016 Mar 1.

21.

Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations.

Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, Westendorp WF, Bredius RG, Kollen WJ, Schölvinck EH, Legger GE, Meyts I, Liston A, Lichtenbelt KD, Giltay JC, Van Haaften G, De Vries Simons GM, Leavis H, Sanders CJ, Bierings MB, Nierkens S, Van Gijn ME.

Rheumatology (Oxford). 2016 May;55(5):902-10. doi: 10.1093/rheumatology/kev439. Epub 2016 Feb 10.

PMID:
26867732
22.

Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.

Admiraal R, van Kesteren C, Jol-van der Zijde CM, Lankester AC, Bierings MB, Egberts TC, van Tol MJ, Knibbe CA, Bredius RG, Boelens JJ.

Lancet Haematol. 2015 May;2(5):e194-203. doi: 10.1016/S2352-3026(15)00045-9. Epub 2015 Apr 21.

PMID:
26688094
23.

Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.

Wiekmeijer AS, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero IL, Lankester AC, Bredius RG, van Dongen JJ, Fibbe WE, Langerak AW, van der Burg M, Staal FJ.

J Allergy Clin Immunol. 2016 Feb;137(2):517-526.e3. doi: 10.1016/j.jaci.2015.08.022. Epub 2015 Oct 4.

PMID:
26441229
24.

Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.

Verhoeven DH, Claas EC, Jol-van der Zijde CM, Thijssen JC, Lankester AC, Bredius RG, Putter H, Kroes AC, Egeler RM, Schilham MW, van Tol MJ.

Pediatr Infect Dis J. 2015 Oct;34(10):1118-27. doi: 10.1097/INF.0000000000000824.

PMID:
26132825
25.

Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome.

Counsilman CE, Jol-van der Zijde CM, Stevens J, Cransberg K, Bredius RG, Sukhai RN.

Pediatr Nephrol. 2015 Aug;30(8):1367-70. doi: 10.1007/s00467-015-3120-8. Epub 2015 Jun 9.

26.

Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.

de Pagter AP, Bredius RG, Kuijpers TW, Tramper J, van der Burg M, van Montfrans J, Driessen GJ; Dutch Working Party for Immunodeficiencies.

Eur J Pediatr. 2015 Sep;174(9):1183-8. doi: 10.1007/s00431-015-2518-4. Epub 2015 Apr 1.

27.

Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.

Willemsen L, Jol-van der Zijde CM, Admiraal R, Putter H, Jansen-Hoogendijk AM, Ostaijen-Ten Dam MM, Wijnen JT, van Kesteren C, Waaijer JL, Lankester AC, Bredius RG, van Tol MJ.

Biol Blood Marrow Transplant. 2015 Mar;21(3):473-82. doi: 10.1016/j.bbmt.2014.11.674. Epub 2014 Dec 5.

28.

Population pharmacokinetic modeling of Thymoglobulin(®) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing.

Admiraal R, van Kesteren C, Jol-van der Zijde CM, van Tol MJ, Bartelink IH, Bredius RG, Boelens JJ, Knibbe CA.

Clin Pharmacokinet. 2015 Apr;54(4):435-46. doi: 10.1007/s40262-014-0214-6.

PMID:
25466602
29.

The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.

Lugthart G, Oomen MA, Jol-van der Zijde CM, Ball LM, Bresters D, Kollen WJ, Smiers FJ, Vermont CL, Bredius RG, Schilham MW, van Tol MJ, Lankester AC.

Biol Blood Marrow Transplant. 2015 Feb;21(2):293-9. doi: 10.1016/j.bbmt.2014.10.012. Epub 2014 Oct 16.

30.

Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy.

Jonkman-Berk BM, van den Berg JM, Ten Berge IJ, Bredius RG, Driessen GJ, Dalm VA, van Dissel JT, van Deuren M, Ellerbroek PM, van der Flier M, van Hagen PM, van Montfrans JM, Rutgers A, Schölvinck EH, de Vries E, van Beem RT, Kuijpers TW.

Clin Immunol. 2015 Feb;156(2):154-62. doi: 10.1016/j.clim.2014.10.003. Epub 2014 Oct 24.

PMID:
25451158
31.

Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation.

Vossen JM, Guiot HF, Lankester AC, Vossen AC, Bredius RG, Wolterbeek R, Bakker HD, Heidt PJ.

PLoS One. 2014 Sep 2;9(9):e105706. doi: 10.1371/journal.pone.0105706. eCollection 2014.

32.

Successful RAG1-SCID gene therapy depends on the level of RAG1 expression.

Pike-Overzet K, Baum C, Bredius RG, Cavazzana M, Driessen GJ, Fibbe WE, Gaspar HB, Hoeben RC, Lagresle-Peyrou C, Lankester A, Meij P, Schambach A, Thrasher A, Van Dongen JJ, Zwaginga JJ, Staal FJ.

J Allergy Clin Immunol. 2014 Jul;134(1):242-3. doi: 10.1016/j.jaci.2014.04.033. Epub 2014 Jun 26. No abstract available.

PMID:
25117803
33.

Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice.

Wiekmeijer AS, Pike-Overzet K, Brugman MH, Salvatori DC, Egeler RM, Bredius RG, Fibbe WE, Staal FJ.

Biores Open Access. 2014 Jun 1;3(3):110-6. doi: 10.1089/biores.2014.0008.

34.

Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics.

ten Brink MH, Zwaveling J, Swen JJ, Bredius RG, Lankester AC, Guchelaar HJ.

Drug Discov Today. 2014 Oct;19(10):1572-86. doi: 10.1016/j.drudis.2014.04.005. Epub 2014 Apr 16. Review.

PMID:
24747172
35.

Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantation.

Ten Brink MH, Ackaert O, Zwaveling J, Bredius RG, Smiers FJ, den Hartigh J, Lankester AC, Guchelaar HJ.

Ther Drug Monit. 2014 Aug;36(4):465-72. doi: 10.1097/FTD.0000000000000047.

PMID:
24487253
36.

Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.

Lugthart G, van Ostaijen-Ten Dam MM, Jol-van der Zijde CM, van Holten TC, Kester MG, Heemskerk MH, Bredius RG, van Tol MJ, Lankester AC.

Biol Blood Marrow Transplant. 2014 May;20(5):655-61. doi: 10.1016/j.bbmt.2014.01.018. Epub 2014 Jan 23.

37.

Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.

Vermont CL, Jol-van der Zijde EC, Hissink Muller P, Ball LM, Bredius RG, Vossen AC, Lankester AC.

Transpl Infect Dis. 2014 Apr;16(2):188-94. doi: 10.1111/tid.12180. Epub 2014 Jan 20.

PMID:
24438482
38.

Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.

Admiraal R, van Kesteren C, Boelens JJ, Bredius RG, Tibboel D, Knibbe CA.

Arch Dis Child. 2014 Mar;99(3):267-72. doi: 10.1136/archdischild-2013-303721. Epub 2013 Dec 19.

PMID:
24356807
39.

Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.

ten Brink MH, van Bavel T, Swen JJ, van der Straaten T, Bredius RG, Lankester AC, Zwaveling J, Guchelaar HJ.

Pharmacogenomics. 2013 Nov;14(14):1683-90. doi: 10.2217/pgs.13.159.

PMID:
24192117
40.

Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.

Savic RM, Cowan MJ, Dvorak CC, Pai SY, Pereira L, Bartelink IH, Boelens JJ, Bredius RG, Wynn RF, Cuvelier GD, Shaw PJ, Slatter MA, Long-Boyle J.

Biol Blood Marrow Transplant. 2013 Nov;19(11):1608-14. doi: 10.1016/j.bbmt.2013.08.014. Epub 2013 Sep 9.

41.

Low complement levels in paediatric systemic lupus erythematosus and the risk of bacteraemia.

Hagen JP, Muller PC, Bredius RG, ten Cate R.

BMJ Case Rep. 2013 Aug 21;2013. pii: bcr2013010378. doi: 10.1136/bcr-2013-010378.

42.

Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients.

Korthof ET, Svahn J, Peffault de Latour R, Terranova P, Moins-Teisserenc H, Socié G, Soulier J, Kok M, Bredius RG, van Tol M, Jol-van der Zijde EC, Pistorio A, Corsolini F, Parodi A, Battaglia F, Pistoia V, Dufour C, Cappelli E.

Am J Hematol. 2013 Jun;88(6):472-6. doi: 10.1002/ajh.23435. Epub 2013 May 2.

43.

Persistence and antiviral resistance of varicella zoster virus in hematological patients.

van der Beek MT, Vermont CL, Bredius RG, Marijt EW, van der Blij-de Brouwer CS, Kroes AC, Claas EC, Vossen AC.

Clin Infect Dis. 2013 Feb;56(3):335-43. doi: 10.1093/cid/cis879. Epub 2012 Oct 16.

PMID:
23074321
44.

Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.

Bartelink IH, Boelens JJ, Bredius RG, Egberts AC, Wang C, Bierings MB, Shaw PJ, Nath CE, Hempel G, Zwaveling J, Danhof M, Knibbe CA.

Clin Pharmacokinet. 2012 May 1;51(5):331-45. doi: 10.2165/11598180-000000000-00000.

PMID:
22455797
45.

Managing a dual role--experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children.

van Walraven SM, Ball LM, Koopman HM, Switzer GE, Ropes-de Jong CM, de Jong A, Bredius RG, Egeler RM.

Psychooncology. 2012 Feb;21(2):168-75. doi: 10.1002/pon.1885. Epub 2010 Dec 19.

PMID:
22271537
46.

Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT.

Jol-van der Zijde CM, Bredius RG, Jansen-Hoogendijk AM, Smiers FJ, Lankester AC, van Tol MJ.

Bone Marrow Transplant. 2012 Sep;47(9):1256-8. doi: 10.1038/bmt.2011.259. Epub 2012 Jan 23. No abstract available.

PMID:
22266763
47.

IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD.

Jol-van der Zijde CM, Bredius RG, Jansen-Hoogendijk AM, Raaijmakers S, Egeler RM, Lankester AC, van Tol MJ.

Bone Marrow Transplant. 2012 Mar;47(3):360-8. doi: 10.1038/bmt.2011.166. Epub 2011 Sep 5.

PMID:
21892212
48.

A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity.

Kuijpers TW, Baars PA, Aan de Kerk DJ, Jansen MH, Derks IA, Bredius RG, Sanders EA, van der Burg M, Alders M, van Lier RA.

J Allergy Clin Immunol. 2011 Dec;128(6):1360-1363.e4. doi: 10.1016/j.jaci.2011.07.001. Epub 2011 Aug 9. No abstract available.

PMID:
21831415
49.

Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man.

Hendriks RW, Bredius RG, Pike-Overzet K, Staal FJ.

Expert Opin Ther Targets. 2011 Aug;15(8):1003-21. doi: 10.1517/14728222.2011.585971. Epub 2011 Jun 2.

PMID:
21635151
50.

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer.

Pike-Overzet K, Rodijk M, Ng YY, Baert MR, Lagresle-Peyrou C, Schambach A, Zhang F, Hoeben RC, Hacein-Bey-Abina S, Lankester AC, Bredius RG, Driessen GJ, Thrasher AJ, Baum C, Cavazzana-Calvo M, van Dongen JJ, Staal FJ.

Leukemia. 2011 Sep;25(9):1471-83. doi: 10.1038/leu.2011.106. Epub 2011 May 27.

PMID:
21617701

Supplemental Content

Loading ...
Support Center